ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Shilpa Medicare gets tentative US FDA nod for multiple sclerosis drug
expressbpd
November 17, 2018The company’s abbreviated new drug application (ANDA) for Dimethyl Fumarate delayed release capsules in the strengths of 120 mg and 240 mg has been granted tentative approval by the United States Food and Drug Administration (US FDA), Shilpa Medicare said
Pharma Sources Insight January 2025
